EKSO vs. CYD, OMSE, RR, AZ, PDYN, AIRJ, GENC, DM, TAYD, and PPIH
Should you be buying Ekso Bionics stock or one of its competitors? The main competitors of Ekso Bionics include China Yuchai International (CYD), OMS Energy Technologies (OMSE), Richtech Robotics (RR), A2Z Smart Technologies (AZ), Palladyne AI (PDYN), Montana Technologies (AIRJ), Gencor Industries (GENC), Desktop Metal (DM), Taylor Devices (TAYD), and Perma-Pipe International (PPIH). These companies are all part of the "machinery" industry.
Ekso Bionics vs. Its Competitors
Ekso Bionics (NASDAQ:EKSO) and China Yuchai International (NYSE:CYD) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, community ranking, profitability, media sentiment, risk and valuation.
Ekso Bionics received 136 more outperform votes than China Yuchai International when rated by MarketBeat users. However, 56.89% of users gave China Yuchai International an outperform vote while only 53.80% of users gave Ekso Bionics an outperform vote.
Ekso Bionics currently has a consensus price target of $562.50, indicating a potential upside of 13,197.87%. Given Ekso Bionics' stronger consensus rating and higher possible upside, equities analysts plainly believe Ekso Bionics is more favorable than China Yuchai International.
Ekso Bionics has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500. Comparatively, China Yuchai International has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500.
China Yuchai International has higher revenue and earnings than Ekso Bionics. Ekso Bionics is trading at a lower price-to-earnings ratio than China Yuchai International, indicating that it is currently the more affordable of the two stocks.
China Yuchai International has a net margin of 0.00% compared to Ekso Bionics' net margin of -62.95%. China Yuchai International's return on equity of 0.00% beat Ekso Bionics' return on equity.
In the previous week, China Yuchai International had 4 more articles in the media than Ekso Bionics. MarketBeat recorded 5 mentions for China Yuchai International and 1 mentions for Ekso Bionics. Ekso Bionics' average media sentiment score of 1.87 beat China Yuchai International's score of 0.56 indicating that Ekso Bionics is being referred to more favorably in the media.
6.4% of Ekso Bionics shares are held by institutional investors. 6.0% of Ekso Bionics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Summary
China Yuchai International beats Ekso Bionics on 9 of the 17 factors compared between the two stocks.
Get Ekso Bionics News Delivered to You Automatically
Sign up to receive the latest news and ratings for EKSO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding EKSO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Ekso Bionics Competitors List
Related Companies and Tools
This page (NASDAQ:EKSO) was last updated on 6/12/2025 by MarketBeat.com Staff